HSBC HOLDINGS PLC - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 242 filers reported holding ACCELERON PHARMA INC in Q3 2020. The put-call ratio across all filers is 0.80 and the average weighting 0.2%.

Quarter-by-quarter ownership
HSBC HOLDINGS PLC ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q1 2021$435,000
-2.2%
3,186
-8.7%
0.00%0.0%
Q4 2020$445,000
+4.5%
3,488
-6.7%
0.00%0.0%
Q3 2020$426,000
-4.7%
3,737
-26.0%
0.00%0.0%
Q1 2020$447,000
+10.1%
5,049
-33.6%
0.00%0.0%
Q4 2019$406,000
+95.2%
7,609
+44.8%
0.00%
Q3 2019$208,000
-11.1%
5,254
-7.7%
0.00%
Q2 2019$234,000
+6.8%
5,691
+21.4%
0.00%
Q1 2019$219,0004,6890.00%
Other shareholders
ACCELERON PHARMA INC shareholders Q3 2020
NameSharesValueWeighting ↓
Polaris Venture Management Co IV LLC 2,803,645$84,782,00078.57%
Cormorant Asset Management, LP 400,000$12,096,0002.49%
Deer VII & Co. Ltd. 175,075$5,294,0002.36%
QVT Financial LP 1,193,258$36,084,0001.86%
Foresite Capital Management I, LLC 55,767$1,686,0001.62%
Perceptive Advisors 445,000$13,457,0001.44%
SECTORAL ASSET MANAGEMENT INC 726,424$21,967,0000.92%
Iguana Healthcare Management, LLC 25,000$756,0000.40%
SPHERA FUNDS MANAGEMENT LTD. 100,000$3,024,0000.37%
Eventide Asset Management 62,100$1,878,0000.26%
View complete list of ACCELERON PHARMA INC shareholders